Science Explorer Interactive view Map
Company · Charleroi · Belgium

Bone Therapeutics

bonetherapeutics.com/enROR OpenAlex
Research works
59
▲ 118% vs 2013–17
Citations
388
6.6 per fractional work
Top-10% rate
13.5%
record average 16.5%
Open access
35%
world 28%

Not ranked overall: Bone Therapeutics is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.07× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 12.31× its world share, 2 worksImmunology and Micro…Neuroscience: 5.42× its world share, 2 worksNeuroscienceChemistry: 1.57× its world share, 0 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials ScienceMedicine: 1.91× its world share, 7 worksMedicineNursing: 2.35× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.3×. Every wedge is a field page.

Which keywords describe research at Bone Therapeutics?

By fractional works in all years, weighted toward what it does more of than the world: Tumor Microenvironment, Inflammation, Therapeutic Targets, Immune Suppression, Neuroprotection, Adenosine Receptors, Purinergic Signalling and Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation9▲ 6.6×18 topics
  2. Tumor Microenvironment8▲ 41×5 topics
  3. Therapeutic Targets6▲ 47×4 topics
  4. Immune Suppression6▲ 177×2 topics
  5. Neuroprotection6▲ 27×3 topics
  6. Adenosine Receptors6▲ 377×1 topic
  7. Purinergic Signalling6▲ 377×1 topic
  8. Immunotherapy5▲ 12×4 topics
  9. Drug Discovery4▲ 19×2 topics
  10. Nanoparticles4▲ 5.8×5 topics
  11. Tumor Targeting4▲ 57×3 topics
  12. Cancer4▲ 5.3×14 topics
  13. Reactive Oxygen Species4▲ 15×3 topics
  14. Oxidative Stress4▲ 3.6×12 topics
  15. Fluorescence Imaging4▲ 54×1 topic
  16. Photothermal Therapy4▲ 71×1 topic
  17. Click Chemistry3▲ 67×1 topic
  18. Copper-Catalyzed Cycloaddition3▲ 163×1 topic
  19. Immunomodulation2▲ 25×3 topics
  20. NK Cell Recognition2▲ 36×1 topic
  21. Natural Killer Cells2▲ 36×1 topic
  22. Stromal Cells2▲ 42×2 topics
  23. Depression2▲ 4.8×4 topics
  24. Mesenchymal Stem Cells2▲ 30×2 topics
  25. Regeneration2▲ 20×2 topics
  26. Differentiation2▲ 46×2 topics
  27. Multipotent2▲ 85×1 topic
  28. Therapeutic2▲ 41×1 topic
  29. Immune Checkpoint Blockade2▲ 57×1 topic
  30. Metabolism2▲ 4.9×4 topics
  31. PD-1 and PD-L12▲ 57×1 topic
  32. Cell Signaling2▲ 9.3×3 topics
  33. Microglia2▲ 34×2 topics
  34. Neuroinflammation2▲ 11×2 topics
  35. Monoclonal Antibodies2▲ 19×2 topics
  36. Fc Receptors2▲ 25×1 topic
  37. Immune Activation2▲ 28×1 topic
  38. Immunity2▲ 7.8×3 topics
  39. Schizophrenia2▲ 20×2 topics
  40. Tryptophan Metabolism2▲ 64×1 topic

Which research topics does Bone Therapeutics publish most on?

By volume in 2022–2025: Adenosine and Purinergic Signaling, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Redox biology and oxidative stress.

Adenosine and Purinergic Signaling: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksImmune Cell Function and…1Immune Cell Function and Interaction: 1 fractional worksRedox biology and oxidat…1Redox biology and oxidative stress: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksInflammation biomarkers and pathways: 0 fractional worksChemokine receptors and …0Chemokine receptors and signaling: 0 fractional worksBiochemical and Molecular Research: 0 fractional worksRNA modifications and cancer: 0 fractional worksNeurological diseases and metabolism: 0 fractional works
PhysiologyOncologyImmunologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Adenosine and Purinergic Signaling Physiology 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Immune Cell Function and Interaction Immunology 1 works
  4. 4 Redox biology and oxidative stress Molecular Biology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Inflammation biomarkers and pathways Immunology 0 works
  7. 7 Chemokine receptors and signaling Oncology 0 works
  8. 8 Biochemical and Molecular Research Molecular Biology 0 works
  9. 9 RNA modifications and cancer Molecular Biology 0 works
  10. 10 Neurological diseases and metabolism Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.3%not open64.7%

World: 28% of research is openly available.

with international co-authors34.2%domestic only65.8%

World: 19% is written across borders.

How has Bone Therapeutics's research output changed?

Output in 2018–2022 was 118% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Charleroi

All research institutions in Charleroi

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.